Updated focus for EME
Created on Monday, 15 Aug 2016.
Following a positive review of the programme and feedback from the research community, a joint MRC-NIHR vision has been developed that allows EME to build on the last five years.
The programme continues to provide a key link in the translational pathway, supporting ambitious studies for the advancement of new interventions for health and patient care.
What has changed? There is a now a much greater emphasis on:
- novel methodologies and study designs that reduces time and cost of evaluation, and increase the value of the study
- the stratification of patients based on biological or genetic characteristics
- use of information captured through digital technology that can shorten timescales or provide additional outputs
- collaborations with other funders from both charity and industry sectors
- integrated studies which could improve the understanding of the mechanisms of both diseases and treatments
- broadening the range of interventions being evaluated, including diagnostic or prognostic tests and decision-making tools, drugs or biological compounds, psychological treatments, medical devices, and public health initiatives delivered within the NHS
Read the full remit to find out more.